Citation Impact
Citing Papers
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
2002 Standout
Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition
2004 Standout
Pharmacologic treatments for temporomandibular disorders
1997
Lansoprazole for the Prevention of Recurrences of Ulcer Complications from Long-Term Low-Dose Aspirin Use
2002 Standout
OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines
2008 Standout
Clopidogrel with or without Omeprazole in Coronary Artery Disease
2010 Standout
First United Kingdom Heart and Renal Protection (UK-HARP-I) study: Biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease
2005 StandoutNobel
Piroxicam-??-Cyclodextrin
1994
Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications
2004 Standout
Anaphylaxis: a 7-year follow-up survey of 46 children
2004
Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: Efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects
1998 Standout
Risk factors for upper gastrointestinal bleeding among end-stage renal disease patients
2003
Drug safety discontinuations in the United Kingdom, the United States, and Spain from 1974 through 1993: A regulatory perspective
1995
Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review
2020 Standout
Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from the American College of Physicians and the American Pain Society
2007 Standout
Individual Nonsteroidal Antiinflammatory Drugs and Other Risk Factors for Upper Gastrointestinal Bleeding and Perforation
1997 Standout
Trends in Acute Nonvariceal Upper Gastrointestinal Bleeding in Dialysis Patients
2012 Standout
Effect of alcohol consumption on the gut
2003
A human whole blood assay for clinical evaluation of biochemical efficacy of cyclooxygenase inhibitors
1996
Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients
2004 Standout
Timing of New Black Box Warnings and Withdrawals for Prescription Medications
2002 Standout
Severe Sepsis and Septic Shock
2013 Standout
Adverse Drug Events Related to Dosage Forms and Delivery Systems
1996
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
The cost effectiveness of rofecoxib and celecoxib in patients with osteoarthritis or rheumatoid arthritis
2003
Does concurrent prescription of selective serotonin reuptake inhibitors and non‐steroidal anti‐inflammatory drugs substantially increase the risk of upper gastrointestinal bleeding?
2005 Standout
Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial
2004 Standout
Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid Arthritis
2000 Standout
Regulation of intestinal epithelial permeability by tight junctions
2012 Standout
Association Between Nonsteroidal Anti-inflammatory Drugs and Upper Gastrointestinal Tract Bleeding/Perforation
2000
Ulcer complications associated with anti‐inflammatory drug use. What is the extent of the disease burden?
2001
Nonsteroidal Anti-inflammatory Drugs and Upper Gastrointestinal Bleeding, Identifying High-Risk Groups by Excess Risk Estimates
1995
IDENTIFYING A NEUROBIOLOGIC BASIS FOR DRUG THERAPY IN TMDS
1996
Dose–response relationships between individual nonaspirin nonsteroidal anti‐inflammatory drugs (NANSAIDs) and serious upper gastrointestinal bleeding: a meta‐analysis based on individual patient data
2002
Gastrointestinal Toxicity of Nonsteroidal Antiinflammatory Drugs
1999 Standout
Updating the Beers Criteria for Potentially Inappropriate Medication Use in Older Adults
2003 Standout
Tumour-associated macrophages as treatment targets in oncology
2017 Standout
Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs
1994
Doctor – How do I use my EpiPen?
2007 Standout
The ChEMBL database in 2017
2016 Standout
Cyclodextrin-based pharmaceutics: past, present and future
2004 Standout
Gastroprotective effects of thymol on acute and chronic ulcers in rats: The role of prostaglandins, ATP-sensitive K+ channels, and gastric mucus secretion
2015
Estimates of benefits and harms of prophylactic use of aspirin in the general population
2014
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
2011 Standout
Hospitalization and mortality rates from peptic ulcer disease and GI bleeding in the 1990s: relationship to sales of nonsteroidal anti-inflammatory drugs and acid suppression medications
2002
Endoscopic perforations of the upper digestive tract: A review of their pathogenesis, prevention, and management
1994
Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin
2001 Standout
Evolving options in the management of esophageal perforation
2004 Standout
‘Cultivating health’: therapeutic landscapes and older people in northern England
2003 Standout
Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis
1996
Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product
1996
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
Alcoholic Liver Disease
2009
Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine
2014 Standout
Anti-inflammatory, analgesic, antipyretic and related properties of meloxicam, a new non-steroidal anti-inflammatory agent with favourable gastrointestinal tolerance
1995
Bleeding Risk with Long-Term Low-Dose Aspirin: A Systematic Review of Observational Studies
2016
Pharmacological Properties and Molecular Mechanisms of Thymol: Prospects for Its Therapeutic Potential and Pharmaceutical Development
2017 Standout
Bias in meta-analysis detected by a simple, graphical test
1997 Standout
Gastrointestinal bleeding in high risk survivors of myocardial infarction: the VALIANT Trial
2009
Hemodynamic monitoring in shock and implications for management
2007
THE RISKS AND COSTS OF UPPER GASTROINTESTINAL DISEASE ATTRIBUTABLE TO NSAIDS
1996
International Consensus Recommendations on the Management of Patients With Nonvariceal Upper Gastrointestinal Bleeding
2010 Standout
Cardiovascular and Overall Mortality Risk in Relation to Alcohol Consumption in Patients With Cardiovascular Disease
2010
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Association between aspirin and upper gastrointestinal complications: Systematic review of epidemiologic studies
2001
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association
2004 Standout
CYCLOOXYGENASES 1 AND 2
1998 StandoutNobel
Temporomandibular Disorders
2008 Standout
Physical Activity and Risk of Severe Gastrointestinal Hemorrhage in Older Persons
1994
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease
2004 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Works of András László being referenced
Nonsteroidal anti-inflammatory drug use in relation to major upper gastrointestinal bleeding
1993
The Risk of Acute Major Upper Gastrointestinal Bleeding Among Users of Aspirin and Ibuprofen at Various Levels of Alcohol Consumption
1999
Clinical Aspects of Upper Gastrointestinal Bleeding Associated With the Use of Nonsteroidal Antiinflammatory Drugs
1998
An epidemiologic study of severe anaphylactic and anaphylactoid reactions among hospital patients: methods and overall risks. The International Collaborative Study of Severe Anaphylaxis.
1998
Clinical aspects of upper gastrointestinal bleeding associated with the use of nonsteroidal antiinflammatory drugs
1998
[Endoscopic sclerotherapy and esophageal varices].
1988
Alcohol consumption and the risk of major upper gastrointestinal bleeding.
1995
An Epidemiologic Study of Severe Anaphylactic and Anaphylactoid Reactions among Hospital Patients
1998